>> 全站文章索引 >> 第17页:
  • Rational Antidepressant Selection-Applying Evidence-Based Medicine to Complex Real-World Patients - [Zetin M, Hoepner CT, Bjornson L.]
  • Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine - [Vered Stearns, Michael D. Johnson, James M. Rae, Alan Morocho, Antonella Novielli, Pankaj Bhargava, Daniel F. Hayes,]
  • Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo - [Charles L Bowden1, Michelle A Collins2, Susan L McElroy3, Joseph R Calabrese4, Alan C Swann5, Richard H Weisler6,7 and Patricia J Wozniak2]
  • Aging, estradiol and time of day differentially affect serotonin transporter binding in the central nervous system of female rats - [Kristine Krajnak, Katherine L. Rosewell, Marilyn J. Duncan and Phyllis M. Wise]
  • Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety - [Sandy Hogg, Line Michan and Maria Jessa]
  • Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. - [Kennedy SH, Andersen HF, Lam RW]
  • Acute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers - [C J Harmer1, Z Bhagwagar1, D I Perrett2, B A V?llm1, P J Cowen1 and G M Goodwin1]
  • Rapid response of emotional incontinence to selective serotonin reuptake inhibitors - [Nahas Z, Arlinghaus KA, Kotrla KJ, Clearman RR, George MS]
  • Electroanalytical determination of paroxetine in pharmaceuticals - [Henri P.A. Nouws, Cristina Delerue-Matos, Aquiles A. Barros and José A. Rodrigues]
  • The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people - [Louis F Draganich, James Zacny, Jerome Klafta, Theodore Karrison]
  • Accelerating response in geriatric depression: A pilot study combining sleep deprivation and paroxetine - [Gregory M. Bump, M.S. 1, Charles F. Reynolds III, M.D. 1 *, Gwenn Smith, Ph.D. 1, Bruce G. Pollock, M.D., Ph.D. 1, Mary Amanda Dew, Ph.D. 1, Sati Mazumdar, Ph.D. 1, Matthew Geary, B.A. 1, Patricia R. Houck, M.S.H. 1, David J. Kupfer, M.D. 2 AD:1Mental Hea]
  • Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly - [Gregory M. Bump, M.D., Benoit H. Mulsant, M.D., Bruce G. Pollock, M.D., Ph.D., Sati Mazumdar, Ph.D., Amy E. Begley, M.A., Mary Amanda Dew, Ph.D., Charles F. Reynolds III, M.D. * AD:Intervention Research Center for Late-Life Mood Disorders, Department of P]
  • A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes - [Paola Rocca, Livio Marchiaro, Roberta Rasetti, Elisa Rivoira and Filippo Bogetto]
  • Predictors of nonresponse to treatment in primary care patients with dysthymia - [Wayne Katon, Joan Russo, Ellen Frank, James Barrett, John W. Williams, Thomas Oxman, Mark Sullivan and John Cornell]
  • Respiratory irregularity and stress hormones in panic disorder exploring potential linkages - [Abelson JL, Khan S, Lyubkin M, Giardino N.]
  • Respiratory irregularity and stress hormones in panic disorder exploring potential linkages - [Abelson JL, Khan S, Lyubkin M, Giardino N.]
  • Depression after stroke - [Castillo, Carlos S.; Robinson, Robert G.]
  • Therapeutic potential of RNA interference for neurological disorders - [Sah DW.]
  • Assessment of the Serotonin and Norepinephrine Reuptake Blocking Properties of Duloxetine in Healthy Subjects - [Julie E Turcotte MD, Guy Debonnel MD, Claude de Montigny MD, Ph.D, Chantal Hébert RN and Pierre Blier MD, Ph.D]
  • Double-blind placebo-controlled pilot study of paroxetine for specific phobia - [J. Benjamin, I. Z. Ben-Zion, E. Karbofsky, P. Dannon]
  • THE RISE AND RISE OF DRUG DELIVERY - [Howard Rosen & Thierry Abribat about the authors]
  • Withdrawal from paroxetine can be severe, warns FDA - [Alison Tonks]
  • Disease mongering and drug marketing - [Howard Wolinsky]
  • Validation of [123I]-CIT SPECT to Assess Serotonin Transporters In Vivo in Humans: a Double-Blind, Placebo-Controlled, Crossover Study with the Selective Serotonin Reuptake Inhibitor Citalopram - [Maartje M L de Win1,2, Jan B A Habraken3, Liesbeth Reneman1, Wim van den Brink4, Gerard J den Heeten1 and Jan Booij3]
  • What has dry cough in common with pruritus? Treatment of dry cough with paroxetine - [Zbigniew Zylicz and Magorzata Krajnik]
  • SENSORY FILTERING PHENOMENOLOGY IN PTSD - [Stewart LP, White PM.]
  • SENSORY FILTERING PHENOMENOLOGY IN PTSD - [Stewart LP, White PM.]
  • Bipolar (Spectrum) Disorder and Mood Stabilization Standing at the Crossroads - [De Fruyt J, Demyttenaere K.]
  • The effect of depression on quality of life of patients with type II diabetes mellitus - [Eren I, Erdi O, Sahin M.]
  • Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine - [Jonathon S. Salsbury *, Paul K. Isbester AD:Albany Molecular Research, Incorporation, Albany, NY 12212-5098, USA]
  • Diminished Sexual Activity, Interest, and Feelings of Attractiveness Among HIV-Infected Women in Two Eras of the AIDS Epidemic - [Siegel K, Schrimshaw EW, Lekas HM.]
  • Genome-wide linkage scan of 98 bipolar pedigrees and analysis of clinical covariates - [Zandi PP, Badner JA, Steele J, Willour VL, Miao K, MacKinnon DF, Mondimore FM, Schweizer B, McInnis MG, DePaulo JR, Gershon E, McMahon FJ, Potash JB.]
  • The biological treatment of dangerous sexual offenders: A review and preliminary report of the Oregon pilot depo-Provera program - [Barry M. Maletzky and Gary Field]
  • Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment - [David Michelson, Jay Amsterdam, Jeffrey Apter, Maurizio Fava, Peter Londborg, Roy Tamura and Lisa Pagh]
  • Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly - [S Govoni1, M Racchi1, E Masoero1, M Zamboni2 and L Ferini-Strambi2]
  • The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression - [Dorotea Mück-eler, Nela Pivac, Marina agud, Miro Jakovljevi and Alma Mihaljevi-Pele]
  • Prognosis of Patients Taking Selective Serotonin Reuptake Inhibitors Before Coronary Artery Bypass Grafting - [Glen L. Xiong, Wei Jiang, Robert Clare, Linda K. Shaw, Peter K. Smith, Kenneth W. Mahaffey, Christopher M. O’Connor, K. Ranga R. Krishnan and L. Kristin Newby]
  • Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression - [Sidney H Kennedy, Kenneth P Evans, Stephanie Kruger, Helen S Mayberg, et al]
  • The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review - [S Williams1 and J Dale1]
  • Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging - [Carolyn Cidis Meltzer MD, Gwenn Smith Ph.D, Steven T DeKosky MD, Bruce G Pollock MD, Ph.D, Chester A Mathis Ph.D, Robert Y Moore MD, Ph.D, David J Kupfer MD and Charles F Reynolds III MD]
  • Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability - [Arturo Zazpe, Inés Artaiz, Luis Labeaga, María Luisa Lucero and Aurelio Orjales]
  • 5-HT1A Receptor Function in Normal Subjects on Clinical Doses of Fluoxetine: Blunted Temperature and Hormone Responses to Ipsapirone Challenge - [Bernard Lerer1 MD, Yevgenia Gelfin1 MD, Malka Gorfine2 MA, Bruno Allolio3 MD, K Peter Lesch4 MD and Michael E Newman1 Ph.D]
  • 广泛性焦虑障碍：一个 40 年回顾性研究 - [Rubio G, López-Ibor JJ.]
  • Epidemiology of subtypes of depression - [Kessing LV.]
  • An Open-Label Study of Lamotrigine Adjunct or Monotherapy for the Treatment of Adolescents With Bipolar Depression - [Chang K, Saxena K, Howe M.]
  • Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. - [Smith GS, Reynolds CF 3rd, Pollock B, Derbyshire S, Nofzinger E, Dew MA, Houck PR, Milko D, Meltzer CC, Kupfer DJ]
  • Sertraline Versus Paroxetine in the Treatment of Panic Disorder An Acute, Double-blind Noninferiority Comparison - [Bandelow B, Behnke K, Lenoir S, Hendriks GJ, Alkin T, Goebel C, Clary CM.]
  • Prediction of response to paroxetine and venlafaxine by serotonin related genes in obsessive-compulsive disorder - [Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG.]
  • Sleep and circadian rhythms in mood disorders - [Armitage R]
  • The Kutcher Adolescent Depression Scale:Assessment of Its Evaluative Properties over theCourse of an 8-Week Pediatric Pharmacotherapy Trial - [Brooks SJ, Krulewicz SP, Kutcher S.]
  • Early Improvement Under Mirtazapine and Paroxetine Predicts Later Stable Response and Remission With High Sensitivity in Patients WITH Major Depression - [Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O.]
  • Impairment of several immune functions in anxious women - [Arranz L, Guayerbas N, De la Fuente M.]
  • Use of mental health services in Europe results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project - [Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autone]
  • [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain - [Cristiana Griffante1, Renzo Carletti1, Filippo Andreetta1 and Mauro Corsi1]
  • Functional consequences of perinatal exposure to3,4-methylenedioxymethamphetamine in rat brain - [Paul A T Kelly, Isobel M Ritchie, Linda Quate, Douglas E McBean, Henry J Olverman]
  • Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps - [Peng Wei, Glenn W. Kaatz and Robert J. Kerns]
  • Acute angle closure glaucoma associated with paroxetine - [T Eke, A K Bates, S Carr]
  • Differential effects of tumor necrosis factor-alpha co-administered with amyloid beta-peptide (25–35) on memory function and hippocampal damage in rat - [Stepanichev M, Zdobnova I, Zarubenko I, Lazareva N, Gulyaeva NV.]
  • Early adversity and alcohol availability persistently modify serotonin and hypothalamic–pituitary–adrenal-axis metabolism and related behavior:What experimental research on rodents and primates can tell us - [Macrì S, Spinelli S, Adriani W, Dee Higley J, Laviola G.]
  • Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression - [Kimura, M. a.; Kanetani, K. b.; Imai, R. c.; Suzuki, H. a.; Isayama, K. b.; Endo, S. a.]
  • Major depression with ischemic heart disease effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. - [Yeragani VK, Roose S, Mallavarapu M, Radhakrishna RK, Pesce V.]
  • Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. - [Yeragani VK, Roose S, Mallavarapu M, Radhakrishna RK, Pesce V]
  • Treatment of mood disorders - [Charles B. Nemeroff & Michael J. Owens]
  • Dementia of Depression in Parkinson's Disease and Stroke - [STARKSTEIN, S. EEGIO; ROBINSON, R. OBERT]
  • Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype - [Catherine Heurteaux, Guillaume Lucas, Nicolas Guy, Malika El Yacoubi, Susanne Th??mmler, Xiao-Dong Peng, Florence Noble, Nicolas Blondeau, Catherine Widmann, Marc Borsotto, Gabriella Gobbi, Jean-Marie Vaugeois, Guy Debonnel, Michel Lazdunski]
  • Tolerability of paroxetine in Parkinson's disease: A prospective study - [Silvana Tesei, MD, Angelo Antonini, MD *, Margherita Canesi, MD, Anna Zecchinelli, MD, Claudio B. Mariani, MD, Gianni Pezzoli, MD AD:Parkinson Center, Department of Neuroscience, Istituti Clinici di Perfezionamento, Milan, Italy]
  • Depression rating scales in Parkinson's disease Critique and recommendations - [Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, Weintraub D, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG.]
  • Effect of SSRI antidepressants on ejaculation a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. - [Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B.]
  • A Systematic Review of Antidepressant Placebo-Controlled Trials for Geriatric Depression: Limitations of Current Data and Directions for the Future - [Warren D Taylor and P Murali Doraiswamy]
  • Depression in older adults exploring the relationship between goal setting and physical health - [Street H, O]
  • Depression in older adults- exploring the relationship between goal setting and physical health - [Street H, O]
  • Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression - [Carolyn Cidis Meltzer1,2,3, Julie C Price1, Chester A Mathis1, Meryl A Butters2, Scott K Ziolko1, Eydie Moses-Kolko2, Sati Mazumdar2,4, Benoit H Mulsant2, Patricia R Houck2, Brian J Lopresti1, Lisa A Weissfeld4 and Charles F Reynolds2,3,5]
  • Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding - [Anna-Carin Wihlb?ck, Inger Sundstr?m Poromaa, Marie Bixo, Per Allard, Tom Mj?rndal and Olav Spigset]
  • Managing rapid metabolizers of antidepressants - [Robert P. Kraus, F.R.C.P.C. *, Paula Diaz, B.Sc. (Hons), M.R. Pharm. S., L.H.S.C., Andrea McEachran, B.A. (Hons), L.H.S.C. AD:Department of Psychiatry, London Health Sciences Centre, Victoria Campus, London, Ontario, Canada]
  • Antidepressants augment natural killer cell activity: in vivo and in vitro. - [Frank MG, Hendricks SE, Johnson DR, Wieseler JL, Burke WJ]
  • Depression and breastfeeding-which postpartum patients take antidepressant medications - [Battle CL, Zlotnick C, Pearlstein T, Miller IW, Howard M, Salisbury A, Stroud L.]
  • Interaction of somatoform and vestibular disorders - [Best C, Eckhardt-Henn A, Diener G, Bense S, Breuer P, Dieterich M.]
  • Chronic paroxetine infusion influences macronutrient selection in male Sprague–Dawley rats - [A. T. M. Konkle, K. B. Sreter, S. L. Baker and C. Bielajew]
  • Paroxetine binding in aggressive schizophrenic patients - [I. Modai, A. Gibel, B. Rauchverger, M. Ritsner, E. Klein and D. Ben Shachar 348.]
  • Paroxetine binding in aggressive schizophrenic patients - [Ilan Modai, Anatoly Gibel, Boris Rauchverger, Michael Ritsner, Ehud Klein and Dorit Ben-Shachar]
  • Comorbidity of panic and depression implications for clinical management - [Ballenger JC.]
  • Therapeutic advances: Paroxetine for the treatment of social anxiety disorder - [R. Bruce Lydiard, Ph.D., M.D. 1 *, Julio Bobes 2 AD:1Department of Psychiatry, Medical University of South Carolina, Charleston, South Carolina2Facultad de Medicina, Universidad de Oviedo, Spain]
  • The Neurotoxic Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Methamphetamine on Serotonin, Dopamine, and GABA-ergic Terminals: An In-Vitro Autoradiographic Study In Rats - [Brian D. Armstrong and Kevin K. Noguchi]
  • Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy - [L Capuron1,2, A Ravaud3, P J Neveu1, A H Miller2, M Maes4 and R Dantzer1]
  • Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity - [M Ingelman-Sundberg1]
  • Serotonin-Mediated Cyclic AMP Inhibitory Pathway in Platelets of Patients - [Liliana Dell]
  • The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care - [Centre for the Economics of Mental Health, Health Services Research Department, Institute of Psychiatry, King]
  • Norepinephrine but not Serotonin Reuptake Inhibitors Enhance Theta and Gamma Activity of the Septo-Hippocampal System - [Mihály Hajós1, William E Hoffmann1, Deborah D Robinson2, Jen H Yu2 and éva Hajós-Korcsok2]
  • Verdict on clinical trials registries? Good, but must do better - [Meredith Wadman]
  • How well do antidepressants work in older people? A systematic review of Number Needed to Treat - [Katona C, Livingston G..]
  • Advances in oral therapy for multiple myeloma - [Morgan GJ, Krishnan B, Jenner M, Davies FE.]
  • Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care a randomized trial - [Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, Stang P, Zhou XH, Hays R, Weinberger M.]
  • Treatment of dysthymia and minor depression in primary care A randomized controlled trial - [Williams JW, Barrett J, Oxman T, Frank E, Katon W, Sullivan M, Cornell J, Sengupta A.]
  • Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.[see comment] - [Ambulatory Care (11C-6), 7400 Merton Minter Blvd, San Antonio, TX 78284, USA. jwilliam@verdict.uthscsa.edu]
  • The next happy pill - [Les Iversen]
  • The endocrine system and ageing - [Chahal HS, Drake WM.]
  • The challenge of depression in late life: Bridging science and service in primary care - [Gallo JJ, Coyne JC]
  • Diagnosing Depression After Stroke - [BLACK, K. EVIN]
  • Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine - [Robert D. Nebes, Bruce G. Pollock, Patricia R. Houck, Meryl A. Butters, Benoit H. Mulsant, Michelle D. Zmuda and Charles F. Reynolds]
  • Cocaine-associated stroke: three cases and rehabilitation considerations - [Raj D. Tolat, Michael W. O]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 [17] 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50